Navigation Links
Prevention of bedsores in long-term care homes cost-effective, study shows
Date:9/26/2011

For all long-term care residents, pressure reduction foam mattresses were cost-effective 82% of the time compared to standard mattresses, with average savings of $115 per resident, the researchers showed. Foam cleansers for incontinence care would be cost-effective 94% of the time compared to soap and water, saving an average of $179 per resident.

The clinical benefits of foam cleansers for bedsores, or "pressure ulcers," however, require confirmation through more research, the team noted.

"These results provide specific evidence to support practice guidelines, which recommend reducing risk factors and improving skin health to prevent pressure ulcers," said Ba' Pham, lead author on the study and a senior research associate with the Toronto Health Economics and Technology Assessment (THETA) Collaborative. "We encourage all providers of long-term care to consider these changes," said Pham, who is completing his doctorate at U of T's Department of Health Policy, Management and Evaluation.

The Archives of Internal Medicine published the study in its current online edition.

In Ontario, there are approximately 72,000 long-term care residents in 89 facilities. As part of their study, the researchers conducted a phone survey with directors of care at 26 of those facilities, and found that only half their beds have pressure reduction foam mattresses. As well, roughly half of incontinence-care cleanings were performed with soap and water rather than foam cleansers.

This slow uptake of quality improvements in pressure ulcer care in Ontario may be connected to the condition's low profile relative to other diseases. "It's one of those diseases that's kind of silent," said Prof. Murray Krahn, principal investigator on the study who is a Professor in the Department of Medicine and the Faculty of Pharmacy at U of T, and Director of THETA.

"Unlike HIV or breast cancer, there are no advocacy groups marching for pressure ulcers. The patients are seniors with co-morbidities and low mobility in long-term care," said Krahn.

Compounding the condition's visibility problem is that it doesn't belong to a particular clinical group. Patients are cared for by nurses, surgeons, infectious disease specialists, general practitioners and internists, so no one group is well-positioned to champion the cause effectively.

Yet, the disease burden for pressure ulcers is huge. From 5% to 10% of all residents in long-term care facilities have pressure ulcers, and a study published this year in the journal Health Affairs, cited by Pham and Krahn, pegged their treatment costs in all health-care settingsincluding hospitals and home careat $3.3 billion U.S. annually. "We've estimated, crudely, that the economic burden for pressure ulcers is similar to diabetes. It's absolutely enormous," said Krahn.

The researchers also evaluated two other strategies for dealing with pressure ulcers: emollients to reduce dry skin, and oral nutritional supplements. They found some evidence that emollients were moderately cost-effective, and that supplements were not cost-effective, although both have been associated with clinical benefits.

Krahn attributes the range and strength of the study's results to the policy-oriented research model for pressure ulcers developed by his colleagues. "It's the work of about 15 people over two years looking at Ontario-specific data, and it's by far the best model in the world in this area," said Krahn.

That model, said Krahn, has produced a very clear message: "There's something relatively easy that can be done about pressure ulcers that will have a relatively large impact."


'/>"/>

Contact: Jim Oldfield
jim.oldfield@utoronto.ca
416-946-8423
University of Toronto
Source:Eurekalert

Related medicine news :

1. Bone experts to present strategies for osteoporosis prevention and care in Dubai
2. Alzheimers disease: The first prevention study of its kind
3. UT awarded NIH grants to study prevention and treatment of neurodegenerative and vascular diseases
4. The prevention of lifestyle diseases has finally reached the top table of the United Nations
5. Major grant awarded for HIV prevention study in Africa
6. Separating a cancer prevention drug from heart disease risk
7. Researchers focus on secondary stroke prevention after study reveals room for improvement
8. A*STAR scientists make headway for cancer treatment and cancer prevention with landmark discovery
9. Stroke prevention trial finds intensive medical treatment has better results than brain stenting
10. Modeling disparities may help with cervical cancer prevention
11. How a cardiovascular prevention program in a Brazilian school reduced parents CVD risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com ... ingestion of their medication by matching users with high quality water pipes within an ... with no commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: